| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Eli Lilly has shown significant success in the product development of weight loss drugs, notably with Mounjaro and Zepbound, driving increased sales. The company is progressing well with its weight loss pill and expanding its pipeline, particularly in the GLP-1 medication category, indicating strong innovation and market presence. However, competitive pressures from new entrants in the GLP-1 market, along with evolving advertising strategies, pose challenges to maintaining market leadership. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -0.3 is modestly bearish. The market sentiment at 0.2 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 1, and the negative at -0.8 on 2026-02-09. The forces of Market Risk Appetite (-4.6), and Stock Price Trend (-0.3) will drive down the price. The forces of Price Level Sentiment (0), Option Sentiment (0.8), Sector Price Trend (0.9), Valuation Sentiment (1.6), and Sentiment towards Fundamentals (3.1) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| LLY | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-09 | 1%(0.6%) | 1044.95 | 2.47% | 43 | -1.21% | -0.16% | -0.3 | -0.2 | 1.5% | 0.2 | Short | 55% | 3.1 | 4.3 |
| 2026-02-08 | 0%(0.4%) | 0.2 | -0.2 | -0.4 | 3 | -1 | ||||||||
| 2026-02-07 | 0%(0.4%) | 0.2 | -0.2 | -0.4 | 3 | -1 | ||||||||
| 2026-02-06 | 0%(0.4%) | 1057.8 | 2.45% | 55 | 3.66% | -0.07% | 0.2 | 0.3 | 2.6% | -0.4 | Long | 55% | 2.9 | -1 |
| 2026-02-05 | 1%(0.6%) | 1020.46 | 2.63% | 19 | -7.88% | -0.64% | -1.1 | -0.9 | 3.8% | -0.6 | Short | 55% | 3.1 | 4.4 |
| 2026-02-04 | 2%(0.4%) | 1107.75 | 2.54% | 94 | 10.45% | 0.29% | 2.1 | 1.5 | 3.4% | -0.2 | Long | 60% | 3.2 | 6.2 |
| 2026-02-03 | 0%(0.1%) | 1002.98 | 2.57% | -2 | -3.85% | -0.37% | -1.3 | -1.2 | 1.9% | -0.5 | Wait | 50% | 2.8 | -1 |
| 2026-02-02 | 0%(0.1%) | 1043.09 | 2.21% | 33 | 0.49% | 0.04% | -0.6 | -0.1 | 0.9% | -0 | Short | 55% | 3.3 | -1 |
| 2026-02-01 | 0%(0.1%) | -0.6 | -0.1 | 0.1 | 3.4 | -1 | ||||||||
| 2026-01-31 | 0%(0.1%) | -0.6 | -0.1 | 0.1 | 3.3 | -1 | ||||||||
| Short is the preferred trading strategy with 55% chance of being right. Weak trend sentiment and negative hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| 2026-02-09 17:02:54 Eli Lilly's strategic partnerships, particularly with Innovent Biologics and the acquisition of Orna Therapeutics, indicate a focus on collaborations in biotechnology to expand its therapeutic capabilities. |
| 2026-02-09 17:02:54 Recent fluctuations in Eli Lilly's stock performance with a slight recent drop, juxtaposed against positive long-term growth predictions from analysts. |
| 2026-02-09 17:02:54 Exploration of how Eli Lilly's revenue from international markets may change, affecting Wall Street predictions and influencing its stock prospects. |
| 2026-02-09 17:02:54 A comparison of market positions shows Eli Lilly's current growth potential compared to Novo Nordisk’s anticipated sales decline due to competitive pressures. |
| 2026-02-09 17:02:54 Eli Lilly's multiple acquisitions and investments, including the buyout of Orna Therapeutics and a collaboration with Innovent Biologics, highlight its aggressive growth strategies and focus on advancing cell therapies. |
| 2026-02-09 11:47:29 Novo Nordisk's lawsuit against Hims & Hers highlights ongoing legal disputes within the industry. |
| 2026-02-09 11:47:29 The fluctuations of stocks like Eli Lilly, Novo Nordisk, and others indicate current market trends and investor sentiment. |
| 2026-02-09 11:47:29 Eli Lilly's strategic acquisition of Orna Therapeutics demonstrates a move towards expanding its product portfolio and strengthening its position in the industry. |
| 2026-02-09 09:32:53 The deal amount signifies a significant financial commitment by Eli Lilly in its pursuit of growth in new therapeutic areas. |
| 2026-02-09 09:32:53 The acquisition indicates Eli Lilly's efforts to expand its therapeutic offerings beyond existing products. |
| 2026-02-09 09:32:53 Eli Lilly's acquisition of Orna Therapeutics highlights a trend in mergers and acquisitions within the biotech sector to enhance product pipelines. |